Article Information
History
- September 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ekasit Kowitdamrong1,2,
- Thanyawee Puthanakit3,4,
- Watsamon Jantarabenjakul3,4,5,
- Eakachai Prompetchara6,7,
- Pintip Suchartlikitwong1,4,
- Opass Putcharoen5,8 and
- Nattiya Hirankarn1,9,*
- 1Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 2Applied Medical Virology Research Unit, Chulalongkorn University, Bangkok, Thailand
- 3Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 4Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand
- 5Thai Red Cross Emerging Infectious Diseases Clinical Centre, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
- 6Center of Excellence in Vaccine Research and Development (ChulaVRC), Chulalongkorn University, Bangkok, Thailand
- 7Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- 8Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 9Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok, Thailand
- ↵*Corresponding author: Email: Nattiya.H{at}chula.ac.th (NH)
Posted September 08, 2020.
Antibody Responses to SARS-CoV-2 in Coronavirus Diseases 2019 Patients with Different Severity
